272 related articles for article (PubMed ID: 26175263)
1. Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells.
Béland K; Marceau G; Labardy A; Bourbonnais S; Alvarez F
Hepatology; 2015 Nov; 62(5):1511-23. PubMed ID: 26175263
[TBL] [Abstract][Full Text] [Related]
2. Low-dose anti-CD3 antibody induces remission of active autoimmune hepatitis in xenoimmunized mice.
Marceau G; Yang R; Lapierre P; Béland K; Alvarez F
Liver Int; 2015 Jan; 35(1):275-84. PubMed ID: 24517723
[TBL] [Abstract][Full Text] [Related]
3. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
[TBL] [Abstract][Full Text] [Related]
4. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
5. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
6. Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis.
Lapierre P; Béland K; Martin C; Alvarez F; Alvarez F
Hepatology; 2010 May; 51(5):1789-98. PubMed ID: 20232291
[TBL] [Abstract][Full Text] [Related]
7. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
[TBL] [Abstract][Full Text] [Related]
8. Autoantigen-selected B cells are bystanders in spontaneous T cell-driven experimental autoimmune hepatitis.
Lübbering D; Preti M; Schlott L; Schultheiß C; Weidemann S; Lohse AW; Binder M; Carambia A; Herkel J
Immunology; 2023 Oct; 170(2):214-229. PubMed ID: 37243425
[TBL] [Abstract][Full Text] [Related]
9. B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model.
Jagessar SA; Heijmans N; Bauer J; Blezer EL; Laman JD; Hellings N; 't Hart BA
J Neuropathol Exp Neurol; 2012 Aug; 71(8):716-28. PubMed ID: 22805775
[TBL] [Abstract][Full Text] [Related]
10. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis.
Renand A; Cervera-Marzal I; Gil L; Dong C; Garcia A; Kervagoret E; Aublé H; Habes S; Chevalier C; Vavasseur F; Clémenceau B; Cardon A; Judor JP; Mosnier JF; Tanné F; Laplaud DA; Brouard S; Gournay J; Milpied P; Conchon S
J Hepatol; 2020 Dec; 73(6):1379-1390. PubMed ID: 32649971
[TBL] [Abstract][Full Text] [Related]
11. B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice.
Liu X; Jiang X; Liu R; Wang L; Qian T; Zheng Y; Deng Y; Huang E; Xu F; Wang JY; Chu Y
Hepatology; 2015 Nov; 62(5):1563-75. PubMed ID: 26207521
[TBL] [Abstract][Full Text] [Related]
12. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
13. B cell depletion therapy exacerbates murine primary biliary cirrhosis.
Dhirapong A; Lleo A; Yang GX; Tsuneyama K; Dunn R; Kehry M; Packard TA; Cambier JC; Liu FT; Lindor K; Coppel RL; Ansari AA; Gershwin ME
Hepatology; 2011 Feb; 53(2):527-35. PubMed ID: 21274873
[TBL] [Abstract][Full Text] [Related]
14. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.
Moritoki Y; Lian ZX; Lindor K; Tuscano J; Tsuneyama K; Zhang W; Ueno Y; Dunn R; Kehry M; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2009 Dec; 50(6):1893-903. PubMed ID: 19877182
[TBL] [Abstract][Full Text] [Related]
15. Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis.
Gil-Farina I; Di Scala M; Salido E; López-Franco E; Rodríguez-García E; Blasi M; Merino J; Aldabe R; Prieto J; Gonzalez-Aseguinolaza G
J Immunol; 2016 Sep; 197(6):2145-56. PubMed ID: 27511737
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration.
Buitrago-Molina LE; Dywicki J; Noyan F; Schepergerdes L; Pietrek J; Lieber M; Schlue J; Manns MP; Wedemeyer H; Jaeckel E; Hardtke-Wolenski M
Cells; 2021 Jun; 10(6):. PubMed ID: 34208308
[TBL] [Abstract][Full Text] [Related]
17. Aetiopathogenesis of autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
[TBL] [Abstract][Full Text] [Related]
18. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
[TBL] [Abstract][Full Text] [Related]
19. B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2h4 mice.
Yu S; Dunn R; Kehry MR; Braley-Mullen H
J Immunol; 2008 Jun; 180(11):7706-13. PubMed ID: 18490774
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance.
Lapierre P; Béland K; Yang R; Alvarez F
Hepatology; 2013 Jan; 57(1):217-27. PubMed ID: 22911361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
